SCHEMBL23381024

SCHEMBL23381024

CC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.60
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
HCRTR1 O43613 1/20 0.57
ERAP2 Q6P179 1/20 0.57
P2RY14 Q15391 1/20 0.57
ECE1 P42892 2/20 0.56
ACE P12821 3/20 0.56
POLB P06746 2/20 0.55
HPGDS O60760 1/20 0.55
HTT P42858 1/20 0.55
TACR1 P25103 2/20 0.54
TP53 P04637 1/20 0.54
NPBWR1 P48145 1/20 0.54
MCHR1 Q99705 1/20 0.54
MMP9 P14780 1/20 0.54
MMP8 P22894 1/20 0.54
MMP14 P50281 1/20 0.54
ITGB2 P05107 1/20 0.54
ICAM1 P05362 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31238592 0.91 ECE1 (0.64) ALOX15MEN1KMT2AHCRTR1ERAP2
SCHEMBL1407979 0.89 ALOX15 (0.68) ALOX15MEN1KMT2AERAP2P2RY14
SCHEMBL30051539 0.89 ALOX15 (0.68) ALOX15MEN1KMT2AERAP2P2RY14
SCHEMBL23380932 0.89 ALOX15 (0.61) ALOX15MEN1KMT2AHCRTR1ERAP2
SCHEMBL1407978 0.89 ALOX15 (0.68) ALOX15MEN1KMT2AERAP2P2RY14
SCHEMBL14300977 0.89 ALOX15 (0.61) ALOX15MEN1KMT2AHCRTR1ERAP2
SCHEMBL23960347 0.88 MMP9 (0.68) MMP9MMP8MMP14
Water SCHEMBL28029902 0.88 ERAP2 (0.67) ALOX15MEN1KMT2AERAP2P2RY14
Water SCHEMBL28029903 0.88 ERAP2 (0.67) ALOX15MEN1KMT2AERAP2P2RY14
SCHEMBL13176572 0.87 TACR1 (0.67) ALOX15MEN1KMT2AACEPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147484-A1 BICYCLIC PEPTIDE LIGANDS AND USES THEREOF BICYCLETX LIMITED (GB) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147484-A1 BICYCLIC PEPTIDE LIGANDS AND USES THEREOF VIP, NGLY1, BID ALOX15 3936/4885MEN1 938/4885KMT2A 4757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.